NCT03265860View on ClinicalTrials.gov

Intravoxel Incoherent Motion Prognostic Value in the Initial Evaluation of Patients With Acute Ischemic Strokes Using 3 Tesla Magnetic Resonance Imaging

CompletedOBSERVATIONAL

Enrollment

274

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

March 14, 2021

Study Completion Date

June 14, 2021

Conditions

StrokeMagnetic Resonance Imaging

Interventions

DEVICE

IntraVoxel Incoherent Motion sequence

The IVIM diffusion sequence with a duration of 2 minutes is added to the imaging protocol.

Trial Locations (1)

Unknown

Fondation Ophtalmologique A. de Rothschild, Paris

All Listed Sponsors

lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT03265860 - Intravoxel Incoherent Motion Prognostic Value in the Initial Evaluation of Patients With Acute Ischemic Strokes Using 3 Tesla Magnetic Resonance Imaging | Biotech Hunter | Biotech Hunter